MLICM
SGNT

Metropolitan Life Insurance Company (MetLife)’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,025
Closed -$255K – 2688
2016
Q2 		$255K Hold
17,025
– – ﹤0.01% 2160
2016
Q1 		$207K Buy
17,025
+770
+5% +$10.8K ﹤0.01% 2158
2015
Q4 		$259K Hold
16,255
– – ﹤0.01% 2066
2015
Q3 		$249K Sell
16,255
-580
-3% -$12.5K ﹤0.01% 2130
2015
Q2 		$409K Sell
16,835
-450
-3% -$10.8K ﹤0.01% 1885
2015
Q1 		$402K Hold
17,285
– – ﹤0.01% 1671
2014
Q4 		$434K Hold
17,285
– – ﹤0.01% 1861
2014
Q3 		$538K Hold
17,285
– – ﹤0.01% 1672
2014
Q2 		$447K Buy
17,285
+3,243
+23% +$72K ﹤0.01% 1919
2014
Q1 		$328K Sell
14,042
-3,948
-22% -$86.3K ﹤0.01% 2094
2013
Q4 		$457K Buy
17,990
+4,020
+29% +$90.8K ﹤0.01% 1869
2013
Q3 		$285K Hold
13,970
– – ﹤0.01% 2148
2013
Q2 		$293K Buy
+13,970
New +$250K ﹤0.01% 2060

Metropolitan Life Insurance Company (MetLife)'s SGNT Position: Q3 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 17,025 shares — an estimated $255K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $538K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 17,025 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $255K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $538K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2016, filed 15 Nov 2016.